The Biocon subsidiary will chart a path that ensures high volumes and
low costs, unlike competitors. The company plans to create an
ecosystem where patients not only have access to the right medicine,
but also gets the right care without always reaching a hospital.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/volume-with-low-cost-is-biocon-biologics-big-plan/articleshow/72325015.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment